Loading...
OTC Markets
Totals
Securities
12,222
Dollar Vol
$2.7B
Share Vol
3.3B
Trades
384,406

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

GENFF
Genflow Biosciences Plc

Ordinary Shares

0.0136

0.00

0.00%

0.007 / 0.0231 (10000 x 10000)

Real-Time Best Bid & Ask: 05:00pm 07/22/2025
Delayed (15 Min) Trade Data: 12:00am 07/21/2025
Genflow Biosciences Plc Company Logo

6 Heddon Street

London, ENG W1B 4BT

United Kingdom

Principal Executive Offices:

6 Heddon Street

London, ENG W1B 4BT

United Kingdom

Business Description
Genflow Biosciences is dedicated to the development and commercialization of novel therapeutics targeting ageing in dogs and humans.
Financial Reporting
Reporting Status
International Reporting: LSE - London Stock Exchange | Main Market
Audited Financials
Audited
Fiscal Year End
12/31
Company Officers & Contacts
Eric J Leire
CEO

MD, MBA

Jonathan Paterson
IR

Emily Bavin
Company Secretary

Nicola Baldwin
Company Secretary

Board of Directors
Tamara Joseph
Chairman, Independent Director, Audit Committee Member

Yassine Bendiabdallah
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Guy Charles La Horie
Independent Director, Compensation Committee Member, Nominating Committee Member

Peter King Lewis
Independent Director, Compensation Committee Member, Nominating Committee Member

Other Company Insiders
Eric Leire
Unknown Unknown
VIDACOS NOMINEES LIMITED
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
PKF Littlejohn

15 Westferry Circus

London, ENG E14 4HD

United Kingdom

Securities Counsel
Galanopoulos & Company

HSBC Building, 885 West Georgia Street,

Suite 1480, Box 1078

Vancouver, BC V6C 3E8

Canada

Securities Counsel
Hill Dickinson LLP

The Broadgate Tower, 20 Primrose Street

London, ENG EC2A 2EW

United Kingdom

Corporate Broker
Clear Capital Markets

20 Primrose Street

London, ENG EC2A 2EW

United Kingdom

Profile Data
SIC - Industry Classification
Not Available
Incorporation Information
ENG, GB, 2021
Employees
1 as of 03/29/2023
Shell
No
Products and Services

The Company is a preclinical biotechnology company focused on the development of innovative biological interventions (namely gene therapies) which are aimed at tackling the effects of ageing, potentially slowing or halting the ageing process and so reducing the incidence of age-related diseases and thereby increasing health span. The Company is seeking to develop treatments that can be applied to both humans and dogs.

Company Facilities

A serviced lab is rented in Belgium.

OTCQB Venture Market Logo
Joined OTCQB 06/2023
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.